Integra LifeSciences Holdings Corporation Partners With TomoTherapy to Deliver Image-Guided Stereotactic Radiosurgery

PLAINSBORO, N.J., Oct. 11, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that its subsidiary, Integra Radionics, Inc., has entered into a strategic alliance with TomoTherapy Incorporated (Nasdaq:TTPY). The companies will develop and supply the InterFix(TM) radiosurgery kit, a collection of stereotactic radiosurgery components for the TomoTherapy(R) Hi-Art(R) system. The Hi-Art(R) treatment system is an advanced radiation delivery system for the treatment of cancer and combines integrated computed tomography (CT) imaging with sophisticated conformal control of target volume irradiation.